SLMXF yields 4065.04% · PFE yields 6.13%● Live data
📍 SLMXF pulled ahead of the other in Year 1
Combined, SLMXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLMXF + PFE for your $10,000?
Slam Exploration Ltd., a resource company, engages in the acquisition, exploration, and development of exploration and evaluation properties in Canada. It primarily explores for gold, silver, base metal, and rare earth metals. The company's flagship project is the Menneval gold project that consists of 8 mineral claims comprising 580 claim units covering an area of 12,450 hectares situated in New Brunswick. The company also holds interest in Benjamin REE property; Birch Lake project; Eighteen Mile property; Jake Lee Gold property; McNair property; Mt. Blair Property; Mt. Victor property; and Flume Ridge Gold property, which comprises 76 claim units covering 1,717 hectares in 2 separate claims located in New Brunswick. In addition, it holds interests in Stephenson Lake Gold project; Wilson Brook Gold project; York Gold project; Gold Brook property; and Pug Hole property. Slam Exploration Ltd. was incorporated in 1996 and is headquartered in Miramichi, Canada.
Full SLMXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.